| Source: HalifaxProj(activate) |
| Type: |
| Autophagy genes, including Atg3, Atg5, Atg6, Atg7, Atg10, Atg12, and Atg17. Tumor autophagy refers to the process by which cancer cells degrade and recycle cellular components through autophagy, a cellular mechanism that helps maintain homeostasis and respond to stress. Autophagy can have dual roles in cancer, acting as both a tumor suppressor and a promoter, depending on the context. Authophagy is the process used by cancer cells to “self-eat” to survive. Authophagy can be both good and bad. If authophagy is prolonged this will become a lethal process to cancer. On the other hand, for a short while (e.g. during chemotheraphy, radiotheraphy, etc.) authophagy is used by cancer cells to survive. For example, Chloroquine is a blocker of autophagy and has been used in a lab setting to dramatically enhance tumor response to radiotherapy, chemotherapy. |
| Cervical Cancer |
| 5432- | AG, | Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies |
| - | Review, | Cerv, | NA |
| 312- | AgNPs, | wortm, | Inhibition of autophagy enhances the anticancer activity of silver nanoparticles |
| - | vitro+vivo, | Cerv, | HeLa |
| 2635- | Api, | CUR, | Synergistic Effect of Apigenin and Curcumin on Apoptosis, Paraptosis and Autophagy-related Cell Death in HeLa Cells |
| - | in-vitro, | Cerv, | HeLa |
| 5585- | BetA, | Betulinic acid-induced mitochondria-dependent cell death is counterbalanced by an autophagic salvage response |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | lymphoma, | U937 |
| 2720- | BetA, | Betulinic acid induces apoptosis of HeLa cells via ROS-dependent ER stress and autophagy in vitro and in vivo |
| - | in-vitro, | Cerv, | HeLa |
| 4479- | Chit, | Chitosan nanoparticles triggered the induction of ROS-mediated cytoprotective autophagy in cancer cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | HCC, | SMMC-7721 cell |
| 477- | CUR, | Curcumin induces G2/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells |
| - | in-vitro, | Cerv, | SiHa |
| 1323- | EMD, | Anticancer action of naturally occurring emodin for the controlling of cervical cancer |
| - | Review, | Cerv, | NA |
| 4968- | PSO, | Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer |
| - | in-vitro, | Cerv, | NA |
| 1993- | PTL, | Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer |
| - | in-vitro, | Cerv, | HeLa |
| 1455- | SFN, | Sulforaphane Activates a lysosome-dependent transcriptional program to mitigate oxidative stress |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | 1321N1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:321 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid